Inactive Instrument

Company Manzo Pharmaceuticals, Inc. Other OTC

Equities

MNZO

US56510D1063

Pharmaceuticals

Business Summary

Manzo Pharmaceuticals, Inc. is a biotechnology company that manufactures and sells products and owns patents in the field of supplemental and holistic cures sold through retail and online distribution. The Company also develops its lactose intolerance product, in which it holds an exclusive patent license. The Company's primary products are dietary supplements, probiotics and natural remedies. The Company's subsidiary, Manzo Pharmaceuticals LLC (Manzo), is an alternative healthcare company with patents for a probiotic remedy for lactose intolerance. The Company also owns other products, including a remedy for babies suffering from colic and/or digestive gas. Manzo's Lacto-Freedom probiotic is a probiotic that aids in the digestion of lactose containing foods, designed specifically for people with lactose sensitivity.

Managers

Managers TitleAgeSince
Chief Executive Officer - -

Company contact information

Manzo Pharmaceuticals, Inc.

6153 Main Street Suite 2

L4A 3R6, Stouffville

+

address Manzo Pharmaceuticals, Inc.(MNZO)
  1. Stock Market
  2. Equities
  3. MNZO Stock
  4. MNZO Stock
  5. Company Manzo Pharmaceuticals, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW